|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 701 to 800 out of 1236 for Cdkn2a

Category restricted to Publication (x)

0.046s

Categories

Category: Publication
Type Details Score
Publication
First Author: Maund SL
Year: 2011
Journal: Cancer Res
Title: Interleukin-1α mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells.
Volume: 71
Issue: 15
Pages: 5276-86
Publication
First Author: Phillips JJ
Year: 2012
Journal: J Clin Invest
Title: Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma.
Volume: 122
Issue: 3
Pages: 911-22
Publication
First Author: Ortiz B
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis.
Volume: 111
Issue: 22
Pages: 8149-54
Publication
First Author: Caganova M
Year: 2013
Journal: J Clin Invest
Title: Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis.
Volume: 123
Issue: 12
Pages: 5009-22
Publication
First Author: Maitituoheti M
Year: 2020
Journal: Cell Rep
Title: Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma.
Volume: 33
Issue: 3
Pages: 108293
Publication
First Author: Shima H
Year: 2018
Journal: Blood
Title: Ring1A and Ring1B inhibit expression of Glis2 to maintain murine MOZ-TIF2 AML stem cells.
Volume: 131
Issue: 16
Pages: 1833-1845
Publication
First Author: Calés C
Year: 2008
Journal: Mol Cell Biol
Title: Inactivation of the polycomb group protein Ring1B unveils an antiproliferative role in hematopoietic cell expansion and cooperation with tumorigenesis associated with Ink4a deletion.
Volume: 28
Issue: 3
Pages: 1018-28
Publication  
First Author: Campagne C
Year: 2017
Journal: Cell Signal
Title: RACK1 cooperates with NRASQ61K to promote melanoma in vivo.
Volume: 36
Pages: 255-266
Publication
First Author: Delmas V
Year: 2007
Journal: Genes Dev
Title: Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development.
Volume: 21
Issue: 22
Pages: 2923-35
Publication
First Author: Kloosterman DJ
Year: 2024
Journal: Cell
Title: Macrophage-mediated myelin recycling fuels brain cancer malignancy.
Volume: 187
Issue: 19
Pages: 5336-5356.e30
Publication
First Author: Nakagawa T
Year: 2015
Journal: Mol Cell Biol
Title: S6 Kinase- and β-TrCP2-Dependent Degradation of p19Arf Is Required for Cell Proliferation.
Volume: 35
Issue: 20
Pages: 3517-27
Publication
First Author: Sotillo R
Year: 2001
Journal: Proc Natl Acad Sci U S A
Title: Invasive melanoma in Cdk4-targeted mice.
Volume: 98
Issue: 23
Pages: 13312-7
Publication
First Author: Jun HJ
Year: 2012
Journal: Oncogene
Title: Acquired MET expression confers resistance to EGFR inhibition in a mouse model of glioblastoma multiforme.
Volume: 31
Issue: 25
Pages: 3039-50
Publication
First Author: Muraguchi T
Year: 2011
Journal: Cancer Res
Title: NKX2.2 suppresses self-renewal of glioma-initiating cells.
Volume: 71
Issue: 3
Pages: 1135-45
Publication
First Author: Li A
Year: 2012
Journal: J Invest Dermatol
Title: Activated mutant NRas(Q61K) drives aberrant melanocyte signaling, survival, and invasiveness via a Rac1-dependent mechanism.
Volume: 132
Issue: 11
Pages: 2610-21
Publication
First Author: Uka R
Year: 2020
Journal: Oncogene
Title: Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth.
Volume: 39
Issue: 20
Pages: 4132-4154
Publication
First Author: Jacobsen JA
Year: 2020
Journal: J Immunol
Title: Ezh2 Represses Transcription of Innate Lymphoid Genes in B Lymphocyte Progenitors and Maintains the B-2 Cell Fate.
Volume: 204
Issue: 7
Pages: 1760-1769
Publication
First Author: Tormo D
Year: 2009
Journal: Cancer Cell
Title: Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells.
Volume: 16
Issue: 2
Pages: 103-14
Publication
First Author: Zhang F
Year: 2018
Journal: Cancer Res
Title: Nanoparticles That Reshape the Tumor Milieu Create a Therapeutic Window for Effective T-cell Therapy in Solid Malignancies.
Volume: 78
Issue: 13
Pages: 3718-3730
Publication
First Author: Yang F
Year: 2024
Journal: Sci Adv
Title: An immunosuppressive vascular niche drives macrophage polarization and immunotherapy resistance in glioblastoma.
Volume: 10
Issue: 9
Pages: eadj4678
Publication
First Author: Zhou Y
Year: 2010
Journal: Nat Biotechnol
Title: Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas.
Volume: 28
Issue: 1
Pages: 71-8
Publication
First Author: Yamashita M
Year: 2013
Journal: Biochem Biophys Res Commun
Title: Nucleostemin is indispensable for the maintenance and genetic stability of hematopoietic stem cells.
Volume: 441
Issue: 1
Pages: 196-201
Publication
First Author: Yeo AT
Year: 2022
Journal: Nat Immunol
Title: Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression.
Volume: 23
Issue: 6
Pages: 971-984
Publication
First Author: Woolfenden S
Year: 2009
Journal: Genesis
Title: A Cre/LoxP conditional luciferase reporter transgenic mouse for bioluminescence monitoring of tumorigenesis.
Volume: 47
Issue: 10
Pages: 659-66
Publication
First Author: Shi C
Year: 2014
Journal: Lab Invest
Title: Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage-stellate cell interaction.
Volume: 94
Issue: 4
Pages: 409-21
Publication
First Author: Morton JP
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer.
Volume: 107
Issue: 1
Pages: 246-51
Publication
First Author: Rai K
Year: 2015
Journal: Cancer Discov
Title: Dual Roles of RNF2 in Melanoma Progression.
Volume: 5
Issue: 12
Pages: 1314-27
Publication  
First Author: Kfoury A
Year: 2018
Journal: EMBO J
Title: AMPK promotes survival of c-Myc-positive melanoma cells by suppressing oxidative stress.
Volume: 37
Issue: 5
Publication
First Author: Fry EA
Year: 2017
Journal: Int J Cancer
Title: Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.
Volume: 140
Issue: 3
Pages: 495-503
Publication
First Author: Ueberham E
Year: 2015
Journal: Mol Cancer Res
Title: Global increase of p16INK4a in APC-deficient mouse liver drives clonal growth of p16INK4a-negative tumors.
Volume: 13
Issue: 2
Pages: 239-49
Publication
First Author: Hosseini M
Year: 2015
Journal: J Invest Dermatol
Title: Premature skin aging features rescued by inhibition of NADPH oxidase activity in XPC-deficient mice.
Volume: 135
Issue: 4
Pages: 1108-1118
Publication
First Author: Kan Q
Year: 2008
Journal: J Biol Chem
Title: Cdc6 determines utilization of p21(WAF1/CIP1)-dependent damage checkpoint in S phase cells.
Volume: 283
Issue: 26
Pages: 17864-72
Publication  
First Author: Shapiro MJ
Year: 2019
Journal: Front Cell Dev Biol
Title: NKAP Regulates Senescence and Cell Death Pathways in Hematopoietic Progenitors.
Volume: 7
Pages: 214
Publication
First Author: Aguilera KY
Year: 2014
Journal: Cancer Res
Title: Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma.
Volume: 74
Issue: 4
Pages: 1032-44
Publication
First Author: Zhang D
Year: 2008
Journal: Oncogene
Title: Aurora A overexpression induces cellular senescence in mammary gland hyperplastic tumors developed in p53-deficient mice.
Volume: 27
Issue: 31
Pages: 4305-14
Publication
First Author: Jongsma J
Year: 2008
Journal: Cancer Cell
Title: A conditional mouse model for malignant mesothelioma.
Volume: 13
Issue: 3
Pages: 261-71
Publication
First Author: Peyre M
Year: 2013
Journal: Oncogene
Title: Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation.
Volume: 32
Issue: 36
Pages: 4264-72
Publication
First Author: Grosso S
Year: 2021
Journal: Nat Commun
Title: The pathogenesis of mesothelioma is driven by a dysregulated translatome.
Volume: 12
Issue: 1
Pages: 4920
Publication  
First Author: Badhai J
Year: 2020
Journal: J Exp Med
Title: Combined deletion of Bap1, Nf2, and Cdkn2ab causes rapid onset of malignant mesothelioma in mice.
Volume: 217
Issue: 6
Publication
First Author: Hönnemann J
Year: 2012
Journal: PLoS One
Title: Miz1 is a critical repressor of cdkn1a during skin tumorigenesis.
Volume: 7
Issue: 4
Pages: e34885
Publication
First Author: Wang C
Year: 2018
Journal: Breast Cancer Res
Title: Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
Volume: 20
Issue: 1
Pages: 74
Publication
First Author: Dodd RD
Year: 2016
Journal: Oncogene
Title: Myogenic transcription factors regulate pro-metastatic miR-182.
Volume: 35
Issue: 14
Pages: 1868-75
Publication
First Author: Guerra C
Year: 2011
Journal: Cancer Cell
Title: Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence.
Volume: 19
Issue: 6
Pages: 728-39
Publication
First Author: Morton JP
Year: 2008
Journal: Am J Pathol
Title: Trp53 deletion stimulates the formation of metastatic pancreatic tumors.
Volume: 172
Issue: 4
Pages: 1081-7
Publication
First Author: Chung WJ
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: Kras mutant genetically engineered mouse models of human cancers are genomically heterogeneous.
Volume: 114
Issue: 51
Pages: E10947-E10955
Publication
First Author: Alvarez R
Year: 2013
Journal: Br J Cancer
Title: Stromal disrupting effects of nab-paclitaxel in pancreatic cancer.
Volume: 109
Issue: 4
Pages: 926-33
Publication
First Author: Zhang F
Year: 2021
Journal: J Bone Miner Res
Title: Disruption of Jmjd3/p16(Ink4a) Signaling Pathway Causes Bizarre Parosteal Osteochondromatous Proliferation (BPOP)-like Lesion in Mice.
Volume: 36
Issue: 10
Pages: 1931-1941
Publication
First Author: Gidekel Friedlander SY
Year: 2009
Journal: Cancer Cell
Title: Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras.
Volume: 16
Issue: 5
Pages: 379-89
Publication
First Author: Genovese G
Year: 2012
Journal: Cancer Discov
Title: microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma.
Volume: 2
Issue: 8
Pages: 736-49
Publication
First Author: Gore AJ
Year: 2014
Journal: J Clin Invest
Title: Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation.
Volume: 124
Issue: 1
Pages: 338-52
Publication
First Author: Ling J
Year: 2012
Journal: Cancer Cell
Title: KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma.
Volume: 21
Issue: 1
Pages: 105-20
Publication
First Author: Boquoi A
Year: 2015
Journal: Aging Cell
Title: Reversible cell cycle inhibition and premature aging features imposed by conditional expression of p16Ink4a.
Volume: 14
Issue: 1
Pages: 139-47
Publication
First Author: van der Weyden L
Year: 2016
Journal: J Pathol
Title: Cross-species models of human melanoma.
Volume: 238
Issue: 2
Pages: 152-65
Publication
First Author: Fasseu M
Year: 2007
Journal: Blood
Title: p16INK4A tumor suppressor gene expression and CD3epsilon deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis.
Volume: 110
Issue: 7
Pages: 2610-9
Publication
First Author: Guha M
Year: 2009
Journal: Cancer Res
Title: Endogenous tumor suppression mediated by PTEN involves survivin gene silencing.
Volume: 69
Issue: 12
Pages: 4954-8
Publication
First Author: Vengoji R
Year: 2021
Journal: J Exp Clin Cancer Res
Title: Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma.
Volume: 40
Issue: 1
Pages: 335
Publication
First Author: Kranc KR
Year: 2003
Journal: Mol Cell Biol
Title: Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast proliferation via Ink4a/ARF.
Volume: 23
Issue: 21
Pages: 7658-66
Publication  
First Author: Gamell C
Year: 2017
Journal: Sci Signal
Title: Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer.
Volume: 10
Issue: 461
Publication
First Author: Limberger T
Year: 2022
Journal: Mol Cancer
Title: KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis.
Volume: 21
Issue: 1
Pages: 89
Publication
First Author: Su J
Year: 2020
Journal: Nature
Title: TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1.
Volume: 577
Issue: 7791
Pages: 566-571
Publication
First Author: Ko RM
Year: 2008
Journal: Leuk Res
Title: Roles of p15Ink4b and p16Ink4a in myeloid differentiation and RUNX1-ETO-associated acute myeloid leukemia.
Volume: 32
Issue: 7
Pages: 1101-11
Publication
First Author: DiNorcia J
Year: 2012
Journal: J Gastrointest Surg
Title: RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer.
Volume: 16
Issue: 1
Pages: 104-12; discussion 112
Publication
First Author: O'Hagan RC
Year: 2003
Journal: Cancer Res
Title: Array comparative genome hybridization for tumor classification and gene discovery in mouse models of malignant melanoma.
Volume: 63
Issue: 17
Pages: 5352-6
Publication
First Author: Karras P
Year: 2022
Journal: Nature
Title: A cellular hierarchy in melanoma uncouples growth and metastasis.
Volume: 610
Issue: 7930
Pages: 190-198
Publication
First Author: Russell JL
Year: 2002
Journal: Mol Cell Biol
Title: ARF differentially modulates apoptosis induced by E2F1 and Myc.
Volume: 22
Issue: 5
Pages: 1360-8
Publication
First Author: Rielland M
Year: 2014
Journal: J Clin Invest
Title: Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression.
Volume: 124
Issue: 5
Pages: 2125-35
Publication
First Author: Zolghadri Y
Year: 2018
Journal: Am J Pathol
Title: Malnutrition in Pancreatic Ductal Adenocarcinoma (PDA): Dietary Pancreatic Enzymes Improve Short-Term Health but Stimulate Tumor Growth.
Volume: 188
Issue: 3
Pages: 616-626
Publication
First Author: Ocal O
Year: 2015
Journal: Dis Model Mech
Title: A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics.
Volume: 8
Issue: 10
Pages: 1201-11
Publication
First Author: Layeghi-Ghalehsoukhteh S
Year: 2020
Journal: Sci Rep
Title: Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics.
Volume: 10
Issue: 1
Pages: 20662
Publication
First Author: Zhao Y
Year: 2020
Journal: Cancer Res
Title: Oncogene-Induced Senescence Limits the Progression of Pancreatic Neoplasia through Production of Activin A.
Volume: 80
Issue: 16
Pages: 3359-3371
Publication
First Author: Ostapoff KT
Year: 2014
Journal: Cancer Res
Title: Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis.
Volume: 74
Issue: 18
Pages: 4996-5007
Publication
First Author: Zhang Y
Year: 2019
Journal: Mol Cancer Res
Title: Cyclooxygenase-2 Inhibition Potentiates the Efficacy of Vascular Endothelial Growth Factor Blockade and Promotes an Immune Stimulatory Microenvironment in Preclinical Models of Pancreatic Cancer.
Volume: 17
Issue: 2
Pages: 348-355
Publication
First Author: Ludwig KF
Year: 2018
Journal: Cancer Res
Title: Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer.
Volume: 78
Issue: 1
Pages: 246-255
Publication
First Author: Wang M
Year: 2015
Journal: Cancer Res
Title: Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer.
Volume: 75
Issue: 23
Pages: 5058-69
Publication
First Author: Wasylishen AR
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Men1 maintains exocrine pancreas homeostasis in response to inflammation and oncogenic stress.
Volume: 117
Issue: 12
Pages: 6622-6629
Publication
First Author: Lashinger LM
Year: 2013
Journal: Cancer Prev Res (Phila)
Title: Dietary energy balance modulation of Kras- and Ink4a/Arf+/--driven pancreatic cancer: the role of insulin-like growth factor-I.
Volume: 6
Issue: 10
Pages: 1046-55
Publication
First Author: Du W
Year: 2021
Journal: Mol Cancer Res
Title: AXL Is a Key Factor for Cell Plasticity and Promotes Metastasis in Pancreatic Cancer.
Volume: 19
Issue: 8
Pages: 1412-1421
Publication
First Author: Thakur AK
Year: 2016
Journal: Cell Death Differ
Title: TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma.
Volume: 23
Issue: 8
Pages: 1358-70
Publication  
First Author: Olivares O
Year: 2017
Journal: Nat Commun
Title: Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions.
Volume: 8
Pages: 16031
Publication  
First Author: Fang Y
Year: 2022
Journal: J Clin Invest
Title: Age-related GSK3β overexpression drives podocyte senescence and glomerular aging.
Volume: 132
Issue: 4
Publication
First Author: Klingler S
Year: 2015
Journal: Cancer Res
Title: Development of Resistance to EGFR-Targeted Therapy in Malignant Glioma Can Occur through EGFR-Dependent and -Independent Mechanisms.
Volume: 75
Issue: 10
Pages: 2109-19
Publication
First Author: Kircher DA
Year: 2019
Journal: Mol Cancer Res
Title: AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis.
Volume: 17
Issue: 9
Pages: 1787-1800
Publication
First Author: Fischer GM
Year: 2019
Journal: Cancer Discov
Title: Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases.
Volume: 9
Issue: 5
Pages: 628-645
Publication
First Author: Wee Y
Year: 2024
Journal: Nat Commun
Title: Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapy.
Volume: 15
Issue: 1
Pages: 6613
Publication
First Author: Maity P
Year: 2021
Journal: Cell Rep
Title: Persistent JunB activation in fibroblasts disrupts stem cell niche interactions enforcing skin aging.
Volume: 36
Issue: 9
Pages: 109634
Publication
First Author: Vaites LP
Year: 2011
Journal: Mol Cell Biol
Title: The Fbx4 tumor suppressor regulates cyclin D1 accumulation and prevents neoplastic transformation.
Volume: 31
Issue: 22
Pages: 4513-23
Publication
First Author: Ramkumar C
Year: 2012
Journal: Cancer Res
Title: Smurf2 regulates the senescence response and suppresses tumorigenesis in mice.
Volume: 72
Issue: 11
Pages: 2714-9
Publication
First Author: Halaban R
Year: 2016
Journal: J Invest Dermatol
Title: RASopathy Gene Mutations in Melanoma.
Volume: 136
Issue: 9
Pages: 1755-9
Publication  
First Author: Jackstadt R
Year: 2013
Journal: Cell Death Dis
Title: AP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation.
Volume: 4
Pages: e775
Publication
First Author: Brady SN
Year: 2004
Journal: Mol Cell Biol
Title: ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.
Volume: 24
Issue: 21
Pages: 9327-38
Publication
First Author: Mitrea DM
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Structural polymorphism in the N-terminal oligomerization domain of NPM1.
Volume: 111
Issue: 12
Pages: 4466-71
Publication
First Author: Brummelkamp TR
Year: 2002
Journal: J Biol Chem
Title: TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence.
Volume: 277
Issue: 8
Pages: 6567-72
Publication
First Author: Zindy F
Year: 1997
Journal: Oncogene
Title: Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging.
Volume: 15
Issue: 2
Pages: 203-11
Publication
First Author: Prives C
Year: 1999
Journal: J Pathol
Title: The p53 pathway.
Volume: 187
Issue: 1
Pages: 112-26
Publication
First Author: Roussel MF
Year: 1999
Journal: Oncogene
Title: The INK4 family of cell cycle inhibitors in cancer.
Volume: 18
Issue: 38
Pages: 5311-7
Publication
First Author: Guo F
Year: 2003
Journal: J Biol Chem
Title: p19Arf-p53 tumor suppressor pathway regulates cell motility by suppression of phosphoinositide 3-kinase and Rac1 GTPase activities.
Volume: 278
Issue: 16
Pages: 14414-9
Publication
First Author: Li J
Year: 2007
Journal: Carcinogenesis
Title: Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability.
Volume: 28
Issue: 6
Pages: 1163-70
Publication  
First Author: Jawad M
Year: 2007
Journal: Br J Radiol
Title: Target cell frequency is a genetically determined risk factor in radiation leukaemogenesis.
Volume: 80 Spec No 1
Pages: S56-62
Publication
First Author: Tzatsos A
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus.
Volume: 106
Issue: 8
Pages: 2641-6
Publication
First Author: Zerrouqi A
Year: 2012
Journal: J Clin Invest
Title: P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3.
Volume: 122
Issue: 4
Pages: 1283-95